about
Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts: a basic science studyContribution of H3K4 methylation by SET-1A to interleukin-1-induced cyclooxygenase 2 and inducible nitric oxide synthase expression in human osteoarthritis chondrocytesCartilage-specific deletion of ephrin-B2 in mice results in early developmental defects and an osteoarthritis-like phenotype during aging in vivo.Systematic review of the association between chronic social stress and telomere length: A life course perspective.PPARgamma ligands as modulators of inflammatory and catabolic responses in arthritis. An overview.Cyclooxygenase-2 and prostaglandins in articular tissues.mPGES-1 as a novel target for arthritis.Association of cartilage-specific deletion of peroxisome proliferator-activated receptor γ with abnormal endochondral ossification and impaired cartilage growth and development in a murine modelEgr-1 contributes to IL-1-mediated down-regulation of peroxisome proliferator-activated receptor γ expression in human osteoarthritic chondrocytesNew thoughts on the pathophysiology of osteoarthritis: one more step toward new therapeutic targets.mPGES-1 null mice are resistant to bleomycin-induced skin fibrosis.Ramipril attenuates lipid peroxidation and cardiac fibrosis in an experimental model of rheumatoid arthritis.Response to 'Ramipril attenuates lipid peroxidation and cardiac fibrosis in an experimental model of rheumatoid arthritis' - authors' reply.Differential modulation of RANKL isoforms by human osteoarthritic subchondral bone osteoblasts: influence of osteotropic factors.Peroxisome proliferator-activated receptor gamma in osteoarthritis.Role of proinflammatory cytokines in the pathophysiology of osteoarthritis.Cellular Aging, Senescence and Autophagy Processes in Osteoarthritis.NFAT3 and TGF-β/SMAD3 regulate the expression of miR-140 in osteoarthritis.An overview of the role of lipid peroxidation-derived 4-hydroxynonenal in osteoarthritis.Elucidating the Role of Protandim and 6-Gingerol in Protection Against Osteoarthritis.Nuclear receptor retinoid-related orphan receptor α1 modulates the metabolic activity of human osteoblasts.Alterations of metabolic activity in human osteoarthritic osteoblasts by lipid peroxidation end product 4-hydroxynonenal.Regulation of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase-activating protein/5-lipoxygenase by 4-hydroxynonenal in human osteoarthritic chondrocytes.Lysine-specific demethylase 1-mediated demethylation of histone H3 lysine 9 contributes to interleukin 1β-induced microsomal prostaglandin E synthase 1 expression in human osteoarthritic chondrocytes4-Hydroxynonenal induces apoptosis in human osteoarthritic chondrocytes: the protective role of glutathione-S-transferasePerturbation of adhesion molecule-mediated chondrocyte-matrix interactions by 4-hydroxynonenal binding: implication in osteoarthritis pathogenesisHuman articular chondrocytes express 15-lipoxygenase-1 and -2: potential role in osteoarthritisIncreased expression of lipocalin-type prostaglandin D2 synthase in osteoarthritic cartilage.Peroxisome proliferator-activated receptor gamma1 expression is diminished in human osteoarthritic cartilage and is downregulated by interleukin-1beta in articular chondrocytes.Activation of proteinase-activated receptor 2 in human osteoarthritic cartilage upregulates catabolic and proinflammatory pathways capable of inducing cartilage degradation: a basic science study.The unfolded protein response genes in human osteoarthritic chondrocytes: PERK emerges as a potential therapeutic target.Differential regulation of cyclooxygenase-2 and inducible nitric oxide synthase by 4-hydroxynonenal in human osteoarthritic chondrocytes through ATF-2/CREB-1 transactivation and concomitant inhibition of NF-kappaB signaling cascade.Nimesulide, a preferential cyclooxygenase 2 inhibitor, suppresses peroxisome proliferator-activated receptor induction of cyclooxygenase 2 gene expression in human synovial fibroblasts: evidence for receptor antagonism.Glucosamine sulfate reduces prostaglandin E(2) production in osteoarthritic chondrocytes through inhibition of microsomal PGE synthase-1.Inhibition of interleukin-1beta-induced matrix metalloproteinases 1 and 13 production in human osteoarthritic chondrocytes by prostaglandin D2.PPARγ deficiency results in severe, accelerated osteoarthritis associated with aberrant mTOR signalling in the articular cartilage.Expression of peroxisome proliferator-activated receptors α, β, γ, and H- and L-prostaglandin D synthase during osteoarthritis in the spontaneous hartley guinea pig and experimental dog models.Activation of peroxisome proliferator-activated receptor gamma inhibits interleukin-1beta-induced membrane-associated prostaglandin E2 synthase-1 expression in human synovial fibroblasts by interfering with Egr-1.Regulation of the expression of 5-lipoxygenase-activating protein/5-lipoxygenase and the synthesis of leukotriene B(4) in osteoarthritic chondrocytes: role of transforming growth factor beta and eicosanoids.Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
P50
Q22000858-2F46392D-2059-4E83-AD6D-A4F93972DCDEQ24300761-C0E6DB92-E26F-4ABD-B2E3-8847C3DE8D80Q27325791-24389D01-6E62-4C20-B1BD-010370DE9167Q34507422-1BAF31F4-B7FB-41E9-98E9-7DCD2E6EF2B0Q34515090-50E07957-B85E-4312-A961-E6F1CF6389FDQ35606373-3FCFF9BF-1C62-498E-ADC2-ED5DED2CD934Q35864732-7C457D75-7CEA-47E9-AF5E-1C21FBD77693Q36198434-2C9DFE5E-57A2-4594-B091-4A3817361859Q36245775-1439EE1F-D2D5-4F66-A47E-1F3357CBAFA5Q36413081-A98F3C2A-F5D0-49A9-98D0-EFBC2887D53EQ36537631-25F8043B-2061-453C-A401-6DCB20F7CE5EQ36633235-1C1F75FD-C0DA-434A-B9B0-B1A8C495C805Q36903199-4DF31BCD-846D-4492-9021-A61EF93F17D4Q37594768-39C34244-3182-477E-8419-4A4D2A069A55Q37785802-FB3711AD-3DB6-4322-9AF9-55833959D697Q37814044-A155E7F0-5679-4432-937A-8B33A23BB7C0Q38554617-556143B0-2184-43D2-8C39-D6EE89DB1941Q38647615-657037B5-AD6A-42B7-AD2E-8FA9F80F9C39Q38817800-D6EE76D4-E8F3-49E2-811B-BCD21C0D92C1Q39555020-B86C89D0-E7CC-4DBD-939B-165F217C85B3Q39561045-67E2A1C5-4BF3-48AE-829D-C681541AF6E7Q40220071-2AFC4D71-0777-4C66-8EB3-4B6591DED76EQ40726810-15E17952-C294-4D9F-93E0-1106AAB5B310Q40796520-A991D2C9-3071-4946-9BD1-3ACAFF070FD1Q41395349-3D65039B-BE27-4577-B3B0-DB38D00F4145Q41554602-6FD852B6-01F0-4EFF-94B8-01279E670892Q41830114-5CE011EB-14DF-49BB-95F8-FF43C3DC9423Q41871857-5CC75CB9-8EC9-4F5A-8584-550BBA455AECQ42109507-00DCF100-73C4-4FD1-8086-76844FF32427Q42249248-1CC8CD8A-4FE8-4BBB-A4C4-4A86A2ACD339Q42411918-A8DEC68C-4236-495B-835A-A6F1D5C35598Q42502519-426EC5CD-F021-41EC-9A7D-1FA7D0D2DAA0Q42517231-63EC6377-95B4-4FC3-8647-3083F705AF08Q42723818-286E975F-411E-4930-B380-30F32B1D16F1Q43161105-2CF8C65F-4122-426A-8E63-C9EBB7356AE3Q43169841-C39436B8-8D38-4E92-A8ED-9F8A2B37D72DQ44329052-8C9D6FD6-9360-4F21-A224-76F95C5F37F4Q44801427-460F4FE8-8530-4BF4-A797-B924A9346EB5Q45184201-515A4BC6-54DD-4C58-85F9-6CF209ED7322Q45217520-EE369FD5-4EC6-4362-9BBC-7E8BE8E8DEAF
P50
name
Hassan Fahmi
@en
type
label
Hassan Fahmi
@en
prefLabel
Hassan Fahmi
@en